Sector Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 150.85 USD | -5.20% |
|
-15.07% | -24.38% |
| 05-13 | Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing | MT |
| 05-13 | Charles River Laboratories and Medipost sign non-exclusive MoU to advance GMP testing solutions | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5.20% | -15.07% | -17.96% | -4.84% | -24.38% | +7.01% | -23.34% | -53.26% | +80.16% | 7.27B | |
| -1.01% | -2.82% | -13.62% | -12.46% | -12.72% | -18.17% | -17.01% | -17.01% | +178.41% | 41.67B | |
| -3.73% | -6.04% | -9.45% | -17.36% | -3.47% | +28.41% | +26.96% | -9.39% | +982.18% | 32.6B | |
| -2.55% | +2.71% | -2.00% | +44.78% | +82.88% | +268.39% | +461.74% | +362.71% | - | 30.97B | |
| -0.91% | -5.37% | -4.16% | +2.85% | -24.97% | +18.41% | -12.40% | -26.94% | +157.88% | 28.23B | |
| -3.23% | -4.84% | -9.01% | -20.67% | +4.31% | +27.50% | +20.01% | -18.85% | +169.06% | 26.41B | |
| -2.03% | +0.77% | - | - | - | - | - | - | - | 14.94B | |
| +6.21% | -2.39% | -0.31% | -9.47% | +36.10% | +176.35% | +4,385.95% | - | - | 14.13B | |
| -1.92% | -1.95% | -1.95% | -8.76% | -6.17% | +121.19% | +104.49% | +98.90% | +127.77% | 12.27B | |
| -0.20% | -0.10% | -15.12% | -10.21% | -5.00% | +5.63% | -0.70% | -28.84% | +82.48% | 12.12B | |
| -0.93% | -2.06% | -20.23% | -3.02% | -26.06% | +35.86% | +98.50% | +155.82% | - | 11.86B | |
| -0.85% | +3.81% | +0.02% | +4.43% | +16.23% | +825.39% | +2,054.59% | +9.02% | - | 9.55B | |
| -4.30% | -6.11% | -5.40% | -8.29% | -17.73% | +1,741.08% | +415.89% | +348.19% | +890.50% | 9.11B | |
| -0.61% | -6.51% | -2.76% | +31.32% | -36.13% | -11.59% | -44.75% | -48.44% | +84.06% | 8.89B | |
| -3.41% | -11.89% | -21.37% | -16.42% | -25.61% | -32.92% | - | - | - | 7.89B | |
| -1.89% | -6.22% | +7.41% | +18.38% | +25.79% | +43.52% | -17.92% | -19.07% | +446.81% | 7.18B | |
| -0.93% | -0.18% | -20.03% | -32.36% | -30.33% | -26.54% | -34.27% | -36.73% | +32.77% | 6.82B | |
| -3.22% | -10.46% | -26.90% | -25.98% | -26.37% | -11.90% | -47.22% | -55.29% | +68.96% | 6.78B | |
| -2.71% | -4.50% | -6.27% | -3.10% | +5.65% | +171.77% | +176.43% | +83.87% | - | 6.76B | |
| -0.04% | -2.28% | -12.73% | -11.07% | -6.47% | +15.66% | -17.70% | -66.08% | - | 6.62B | |
| Average | -1.67% | -4.03% | -9.57% | -4.33% | -3.92% | +178.16% | +418.29% | +39.92% | +275.09% | 15.1B | |
| Weighted average by Cap. | -1.69% | -3.14% | -8.74% | -2.94% | +1.69% | +135.68% | +366.40% | +50.85% | +322.51% |
- Stock Market
- Equities
- CRL Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition